| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 3.5K | 8.2% |
| Total Income | 3.5K | 8.2% |
| Expenditure | 3.6K | 41.4% |
| PBT | -247.30 | 92.0% |
| Net Profit | 176.40 | 105.8% |
| OPM | -2.27% | 86.60pp |
| NPM | 5.03% | 98.82pp |
| EPS | 0.15 | 105.9% |
Viatris Reports Q1 2026 Revenue of $3.5 Billion, Up 8% Reported
07 May 2026 · 7 May, 5:22 pm
Summary
Viatris Inc. announced its first-quarter 2026 financial results, reporting total revenues of $3.5 billion, an 8% increase compared to the first quarter of 2025. Adjusted EBITDA reached $1.0 billion, reflecting a 10% operational increase. The company is reaffirming its 2026 financial guidance. Viatris generated U.S. GAAP net earnings of $176 million, a significant improvement from the $3.0 billion net loss in the same period last year.
Key Highlights
- 1
Viatris reported total revenues of $3.5 billion, representing 8% reported growth compared to the first quarter of 2025.
- 2
Operationally, total revenues were up 3% compared to the first quarter of 2025.
- 3
Adjusted EBITDA was $1.0 billion, up 10% operationally compared to the first quarter of 2025.
- 4
The company progressed key launches and pipeline milestones across multiple products, including the launch of Effexor® for Generalized Anxiety Disorder in Japan.
- 5
Viatris continues to expect more than $2.5 billion of cash available for deployment in 2026.
- 6
U.S. GAAP net earnings were $176 million compared to a U.S. GAAP net loss of $3.0 billion in the first quarter of 2025.
Management Comments
Scott A. Smith
“We delivered a strong first quarter, reflecting disciplined execution across our global businesses. Our performance reinforces the growth trajectory we outlined at our Investor Event in March. We saw continued momentum in key markets like Greater China and North America, progressed on launches and advanced our pipeline with multiple near-term catalysts. We expect to generate significant cash in 2026, providing flexibility to execute against our balanced capital allocation framework. Based on our strong start, we believe we are well positioned to deliver on our full-year guidance, and we remain focused on building a more durable, higher-quality growth profile for Viatris.”
Informational and educational content only. Not investment advice.